Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Genetic Obesity Drug Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global Genetic Obesity Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetic Obesity Drug Overall Market Size
2.1 Global Genetic Obesity Drug Market Size: 2021 VS 2028
2.2 Global Genetic Obesity Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Genetic Obesity Drug Players in Global Market
3.2 Top Global Genetic Obesity Drug Companies Ranked by Revenue
3.3 Global Genetic Obesity Drug Revenue by Companies
3.4 Top 3 and Top 5 Genetic Obesity Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genetic Obesity Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genetic Obesity Drug Players in Global Market
3.6.1 List of Global Tier 1 Genetic Obesity Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Genetic Obesity Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Drug Type - Global Genetic Obesity Drug Market Size Markets, 2021 & 2028
4.1.2 Sibutramine
4.1.3 Orlistat
4.1.4 Sympathomimetic Drugs
4.1.5 Receptors Antagonists
4.1.6 Others
4.2 By Drug Type - Global Genetic Obesity Drug Revenue & Forecasts
4.2.1 By Drug Type - Global Genetic Obesity Drug Revenue, 2017-2022
4.2.2 By Drug Type - Global Genetic Obesity Drug Revenue, 2023-2028
4.2.3 By Drug Type - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetic Obesity Drug Market Size, 2021 & 2028
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Genetic Obesity Drug Revenue & Forecasts
5.2.1 By Application - Global Genetic Obesity Drug Revenue, 2017-2022
5.2.2 By Application - Global Genetic Obesity Drug Revenue, 2023-2028
5.2.3 By Application - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Genetic Obesity Drug Market Size, 2021 & 2028
6.2 By Region - Global Genetic Obesity Drug Revenue & Forecasts
6.2.1 By Region - Global Genetic Obesity Drug Revenue, 2017-2022
6.2.2 By Region - Global Genetic Obesity Drug Revenue, 2023-2028
6.2.3 By Region - Global Genetic Obesity Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genetic Obesity Drug Revenue, 2017-2028
6.3.2 US Genetic Obesity Drug Market Size, 2017-2028
6.3.3 Canada Genetic Obesity Drug Market Size, 2017-2028
6.3.4 Mexico Genetic Obesity Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genetic Obesity Drug Revenue, 2017-2028
6.4.2 Germany Genetic Obesity Drug Market Size, 2017-2028
6.4.3 France Genetic Obesity Drug Market Size, 2017-2028
6.4.4 U.K. Genetic Obesity Drug Market Size, 2017-2028
6.4.5 Italy Genetic Obesity Drug Market Size, 2017-2028
6.4.6 Russia Genetic Obesity Drug Market Size, 2017-2028
6.4.7 Nordic Countries Genetic Obesity Drug Market Size, 2017-2028
6.4.8 Benelux Genetic Obesity Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genetic Obesity Drug Revenue, 2017-2028
6.5.2 China Genetic Obesity Drug Market Size, 2017-2028
6.5.3 Japan Genetic Obesity Drug Market Size, 2017-2028
6.5.4 South Korea Genetic Obesity Drug Market Size, 2017-2028
6.5.5 Southeast Asia Genetic Obesity Drug Market Size, 2017-2028
6.5.6 India Genetic Obesity Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genetic Obesity Drug Revenue, 2017-2028
6.6.2 Brazil Genetic Obesity Drug Market Size, 2017-2028
6.6.3 Argentina Genetic Obesity Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genetic Obesity Drug Revenue, 2017-2028
6.7.2 Turkey Genetic Obesity Drug Market Size, 2017-2028
6.7.3 Israel Genetic Obesity Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Genetic Obesity Drug Market Size, 2017-2028
6.7.5 UAE Genetic Obesity Drug Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Genetic Obesity Drug Major Product Offerings
7.1.4 Pfizer, Inc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.1.5 Pfizer, Inc. Key News
7.2 Sanofi.
7.2.1 Sanofi. Corporate Summary
7.2.2 Sanofi. Business Overview
7.2.3 Sanofi. Genetic Obesity Drug Major Product Offerings
7.2.4 Sanofi. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.2.5 Sanofi. Key News
7.3 Tonghua Dongbao Pharmaceutical Co., Ltd.
7.3.1 Tonghua Dongbao Pharmaceutical Co., Ltd. Corporate Summary
7.3.2 Tonghua Dongbao Pharmaceutical Co., Ltd. Business Overview
7.3.3 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Major Product Offerings
7.3.4 Tonghua Dongbao Pharmaceutical Co., Ltd. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.3.5 Tonghua Dongbao Pharmaceutical Co., Ltd. Key News
7.4 Biocon.
7.4.1 Biocon. Corporate Summary
7.4.2 Biocon. Business Overview
7.4.3 Biocon. Genetic Obesity Drug Major Product Offerings
7.4.4 Biocon. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.4.5 Biocon. Key News
7.5 Adocia
7.5.1 Adocia Corporate Summary
7.5.2 Adocia Business Overview
7.5.3 Adocia Genetic Obesity Drug Major Product Offerings
7.5.4 Adocia Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.5.5 Adocia Key News
7.6 GlaxoSmithKline Plc.
7.6.1 GlaxoSmithKline Plc. Corporate Summary
7.6.2 GlaxoSmithKline Plc. Business Overview
7.6.3 GlaxoSmithKline Plc. Genetic Obesity Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Plc. Key News
7.7 Novo Nordisk A/S.
7.7.1 Novo Nordisk A/S. Corporate Summary
7.7.2 Novo Nordisk A/S. Business Overview
7.7.3 Novo Nordisk A/S. Genetic Obesity Drug Major Product Offerings
7.7.4 Novo Nordisk A/S. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.7.5 Novo Nordisk A/S. Key News
7.8 Oramed Pharmaceuticals, Inc
7.8.1 Oramed Pharmaceuticals, Inc Corporate Summary
7.8.2 Oramed Pharmaceuticals, Inc Business Overview
7.8.3 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Major Product Offerings
7.8.4 Oramed Pharmaceuticals, Inc Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.8.5 Oramed Pharmaceuticals, Inc Key News
7.9 Wockhardt.
7.9.1 Wockhardt. Corporate Summary
7.9.2 Wockhardt. Business Overview
7.9.3 Wockhardt. Genetic Obesity Drug Major Product Offerings
7.9.4 Wockhardt. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.9.5 Wockhardt. Key News
7.10 Eli Lilly and Company.
7.10.1 Eli Lilly and Company. Corporate Summary
7.10.2 Eli Lilly and Company. Business Overview
7.10.3 Eli Lilly and Company. Genetic Obesity Drug Major Product Offerings
7.10.4 Eli Lilly and Company. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.10.5 Eli Lilly and Company. Key News
7.11 Merck & Co., Inc.
7.11.1 Merck & Co., Inc. Corporate Summary
7.11.2 Merck & Co., Inc. Business Overview
7.11.3 Merck & Co., Inc. Genetic Obesity Drug Major Product Offerings
7.11.4 Merck & Co., Inc. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.11.5 Merck & Co., Inc. Key News
7.12 Julphar.
7.12.1 Julphar. Corporate Summary
7.12.2 Julphar. Business Overview
7.12.3 Julphar. Genetic Obesity Drug Major Product Offerings
7.12.4 Julphar. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.12.5 Julphar. Key News
7.13 Bristol-Myers Squibb Company.
7.13.1 Bristol-Myers Squibb Company. Corporate Summary
7.13.2 Bristol-Myers Squibb Company. Business Overview
7.13.3 Bristol-Myers Squibb Company. Genetic Obesity Drug Major Product Offerings
7.13.4 Bristol-Myers Squibb Company. Genetic Obesity Drug Revenue in Global Market (2017-2022)
7.13.5 Bristol-Myers Squibb Company. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer